Population-based retrospective nested case-control study evaluating effectiveness of GARDASIL™ /GARDASIL™9 against adult-onset recurrent respiratory papillomatosis (AoRRP) in Sweden, Denmark, and Norway (V503-088)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Sweden National Prescribed Drugs Register / Läkemedelsregistret

  The Cancer Registry of Norway
• Data source(s), other:
  - National Vaccination Registry and Swedish Vaccination Registry (SVEVAC), Sweden ; - Total Population Registry and National Patient Registry, Sweden; - Longitudinal Integrated database for Health insurance and Labour market studies (LISA), Sweden; - Multigenerational registry, Sweden; - Population Registry (Danish Civil Registration System), Denmark ; - National Patient Registry and National Health Service Registry, Denmark ; - National Prescription Register, Denmark ; - Statistics Denmark ; - Pathology Register, Denmark ; - National population registry, Norway; - Norwegian patient registry; - Norwegian Prescribed Drug Registry; - Norwegian Immunisation Registry (SYSVAK); - Statistics Norway
• Data sources (types):
  Disease registry

  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

  Non-interventional study

  Other

  Population registry
• Data sources (types), other:
  Prospective patient-based data collection and exposure registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Unknown
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Yes